Recommended NSAID Dosing for Typical Adults
For a typical adult with no significant medical history, start with ibuprofen 400 mg every 4-6 hours as needed (maximum 3200 mg/day) or naproxen 500 mg twice daily (maximum 1000 mg/day), using the lowest effective dose for the shortest duration. 1, 2, 3
First-Line NSAID Selection and Dosing
Ibuprofen (Preferred Initial Option)
- Standard dose: 400-600 mg every 4-6 hours 1, 3
- Maximum daily dose: 3200 mg, though doses above 2400 mg rarely provide additional benefit 3
- For mild-to-moderate pain, 400 mg every 4-6 hours is typically sufficient, as controlled trials show doses above 400 mg are no more effective for analgesia 3
- Take with food or milk if gastrointestinal complaints occur 3
Naproxen (Alternative First-Line)
- Standard dose: 500 mg twice daily (every 12 hours) 2
- Alternative dosing: 375-500 mg twice daily for chronic inflammatory conditions 2
- Maximum daily dose: 1000 mg for routine long-term use 2
- For acute pain: 275-550 mg every 2-6 hours, with maximum initial dose of 825 mg and not exceeding 1500 mg/day 2
Other NSAID Options
If ibuprofen or naproxen are ineffective or not tolerated, consider 4:
- Diclofenac: 150 mg/day in divided doses initially, maintenance 75-100 mg/day
- Indomethacin: 150 mg/day in divided doses
- Celecoxib: 200-400 mg/day in divided doses
- Meloxicam: 15 mg/day in one dose
- Etoricoxib: 90 mg/day (or temporarily 120 mg/day)
Treatment Duration and Response Assessment
- Initial trial: 2-4 weeks at maximum tolerated dose 4, 2
- Evaluate response at 2-4 weeks; if insufficient, consider switching to another NSAID 4, 2
- If response is sufficient at 2-4 weeks, continue treatment and consider tapering or switching to on-demand dosing after 12 weeks of sustained response 4
- If two different NSAIDs fail sequentially, switch to alternative analgesic approaches 2
Critical Safety Principles
Universal Precautions
Always use the lowest effective dose for the shortest duration consistent with treatment goals to minimize gastrointestinal, cardiovascular, and renal adverse effects 1, 5, 6. This FDA recommendation applies to all NSAIDs regardless of patient age or comorbidities 5.
Gastrointestinal Risk Management
- The average relative risk of serious GI complications with NSAIDs is 5-6 fold higher than non-users 4
- Risk is dose-dependent and increases linearly with duration of use 4, 2
- For patients with GI risk factors (age ≥75, history of peptic ulcer, prior GI bleeding, concurrent anticoagulants/antiplatelets/SSRIs/corticosteroids), add proton pump inhibitor or misoprostol for gastroprotection 2, 7
Cardiovascular Considerations
- All NSAIDs carry cardiovascular risk, though the profile differs between agents 4
- Use with extreme caution in patients with cardiovascular disease or congestive heart failure 2, 7
- If patient takes low-dose aspirin for cardioprotection, take ibuprofen at least 30 minutes after immediate-release aspirin or at least 8 hours before aspirin to avoid interference with aspirin's antiplatelet effects 1, 7
Renal Safety
- Avoid NSAIDs in patients with creatinine clearance <10-30 mL/min 7
- Use with extreme caution in patients with compromised fluid status or taking concurrent nephrotoxic drugs 2
Common Pitfalls to Avoid
Never combine multiple NSAIDs (including OTC products and low-dose aspirin combinations), as this increases risk without additional benefit 2, 7
Account for "hidden" NSAIDs in combination products (e.g., cold medications, headache remedies) 7
Do not use prolonged courses without reassessing benefits and risks 1
Avoid assuming all NSAIDs are equivalent—they have different GI and cardiovascular risk profiles 4
For older adults (≥60-75 years), start with lower doses due to increased risk of adverse effects; consider acetaminophen (up to 3-4 g daily) as first-line before escalating to NSAIDs 4, 7
Monitoring for Chronic Use
If NSAIDs are continued beyond 2-4 weeks, monitor 2, 7:
- Blood pressure
- Renal function (BUN, creatinine)
- Liver function tests
- Complete blood count
- Fecal occult blood
Discontinue immediately if: GI bleeding occurs, BUN/creatinine doubles, liver enzymes increase to 3× upper limit of normal, or hypertension develops/worsens 2.